BEVALTI
Dead / Abandoned — Abandoned — failure to respond (as of 20 Oct 2025)
What this means for you
This application is over — abandoned 06 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98771026
- Mark type
- Stylized text
- Filed
- 26 Sept 2024
- Abandoned
- 06 Oct 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
- Class 041 — Education and entertainment services: Medical training and teaching
- Class 044 — Medical, beauty and agricultural services: Medical services; providing health information
Owner
- Sarepta Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 20 Oct 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 20 Oct 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 04 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Jul 2025 — NON-FINAL ACTION E-MAILED
- 04 Jul 2025 — NON-FINAL ACTION WRITTEN
- 23 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Apr 2025 — NON-FINAL ACTION E-MAILED
- 23 Apr 2025 — NON-FINAL ACTION WRITTEN
- 15 Apr 2025 — ASSIGNED TO EXAMINER
- 14 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Sept 2024 — NEW APPLICATION ENTERED